Winfield Associates’s US Physical Therapy USPH Stock Holding History

Winfield Associates’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-92	Closed	-$6K	–	896
2017 Q2	$6K	Buy	+92	New	+$5.88K	﹤0.01%	499

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winfield Associates's USPH Position: Q3 2017 in Review

Winfield Associates sold out of US Physical Therapy (USPH) in Q3 2017, closing a stake of 92 shares — an estimated $6K sold.

Winfield Associates first reported a position in USPH in Q2 2017 and held it in 1 quarter. The position peaked at $6K in Q2 2017. 167 funds tracked by Wall St. Rank hold USPH as of Q3 2017.

Winfield Associates reported no remaining US Physical Therapy position as of Q3 2017 after selling out during the quarter.
Winfield Associates sold 92 US Physical Therapy shares in Q3 2017, an estimated $6K.
Winfield Associates first reported a position in US Physical Therapy in Q2 2017 and held it in 1 quarter.
Winfield Associates's US Physical Therapy position peaked at $6K in Q2 2017.
167 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2017.

Based on Winfield Associates's 13F filing for Q3 2017, filed 6 Nov 2017.